Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Prostate Cancer

  Free Subscription


Articles published in Am J Clin Oncol

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    June 2008
  1. BITTNER N , Wallner K, Merrick G, Orio P, et al
    The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure.
    Am J Clin Oncol. 2008;31:231-6.
    PubMed     Related articles    Abstract available


    April 2008
  2. AZUMA H , Sakamoto T, Kiyama S, Ubai T, et al
    Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer.
    Am J Clin Oncol. 2008;31:188-94.
    PubMed     Related articles    Abstract available


    February 2008
  3. HERSTEIN A , Wallner K, Merrick G, Orio P, et al
    There is a wide range of predictive dosimetric factors for I-125 and pd-103 prostate brachytherapy.
    Am J Clin Oncol. 2008;31:6-10.
    PubMed     Related articles    Abstract available


    December 2007
  4. MITSUYAMA H , Wallner K, Merrick G, Virgin J, et al
    The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapy.
    Am J Clin Oncol. 2007;30:597-600.
    PubMed     Related articles    Abstract available


  5. WELSH JS , Limmer JP
    Dosimetric concerns regarding the 4-field box technique.
    Am J Clin Oncol. 2007;30:666.
    PubMed     Related articles   


  6. CHANG BK , Timmerman RD
    Stereotactic body radiation therapy: a comprehensive review.
    Am J Clin Oncol. 2007;30:637-44.
    PubMed     Related articles    Abstract available


  7. MERRICK GS , Galbreath RW, Butler WM, Wallner KE, et al
    Obesity is not predictive of overall survival following permanent prostate brachytherapy.
    Am J Clin Oncol. 2007;30:588-96.
    PubMed     Related articles    Abstract available


    October 2007
  8. THARP M , Bennett R, Burns J, Jones WT, et al
    Prostate high dose rate brachytherapy in a free-standing cancer center setting.
    Am J Clin Oncol. 2007;30:520-5.
    PubMed     Related articles    Abstract available


    August 2007
  9. TEH BS , Bastasch MD, Mai WY, Kadmon D, et al
    Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomy.
    Am J Clin Oncol. 2007;30:395-400.
    PubMed     Related articles    Abstract available


    June 2007
  10. CHIAPPINO I , Destefanis P, Addeo A, Galetto A, et al
    Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer.
    Am J Clin Oncol. 2007;30:234-8.
    PubMed     Related articles    Abstract available


  11. SU AW , Jani AB
    Chronic genitourinary and gastrointestinal toxicity of prostate cancer patients undergoing pelvic radiotherapy with intensity-modulated versus 4-field technique.
    Am J Clin Oncol. 2007;30:215-9.
    PubMed     Related articles    Abstract available


  12. MERRICK GS , Butler WM, Wallner KE, Allen ZA, et al
    Dosimetry of an extracapsular anulus following permanent prostate brachytherapy.
    Am J Clin Oncol. 2007;30:228-33.
    PubMed     Related articles    Abstract available


    April 2007
  13. PAPAGIKOS MA , Rossi PJ, Urbanic JJ, deGuzman AF, et al
    A simple model predicts freedom from biochemical recurrence after low-dose rate prostate brachytherapy alone.
    Am J Clin Oncol. 2007;30:199-204.
    PubMed     Related articles    Abstract available


    December 2006
  14. GIRNIUS S , Cersonsky N, Gesell L, Cico S, et al
    Treatment of refractory radiation-induced hemorrhagic proctitis with hyperbaric oxygen therapy.
    Am J Clin Oncol. 2006;29:588-92.
    PubMed     Related articles    Abstract available


    October 2006
  15. CRAWFORD ED , Kavanagh BD
    The role of alpha-blockers in the management of lower urinary tract symptoms in prostate cancer patients treated with radiation therapy.
    Am J Clin Oncol. 2006;29:517-23.
    PubMed     Related articles    Abstract available


  16. FARIA SL , Mahmud S, Wakil G, Negrete S, et al
    Is there a detrimental effect of waiting for radiotherapy for patients with localized prostate cancer?
    Am J Clin Oncol. 2006;29:463-7.
    PubMed     Related articles    Abstract available


  17. FEIGENBERG SJ , Hanlon AL, Horwitz EM, Uzzo RG, et al
    A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancer.
    Am J Clin Oncol. 2006;29:458-62.
    PubMed     Related articles    Abstract available


  18. VARGAS CE , Demanes J, Boike TP, Barnaba MC, et al
    Matched-pair analysis of prostate cancer patients with a high risk of positive pelvic lymph nodes treated with and without pelvic RT and high-dose radiation using high dose rate brachytherapy.
    Am J Clin Oncol. 2006;29:451-7.
    PubMed     Related articles    Abstract available


  19. SYMON Z , Kundel Y, Sadetzki S, Oberman B, et al
    Radiation rescue for biochemical failure after surgery for prostate cancer: predictive parameters and an assessment of contemporary predictive models.
    Am J Clin Oncol. 2006;29:446-50.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: